Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree(TM)) in Healthy Adult Subjects

BACKGROUND AND OBJECTIVES: Viloxazine extended-release (viloxazine ER) capsules (Qelbree(TM)) is a novel nonstimulant recently approved as a treatment for attention-deficit/hyperactivity disorder in children and adolescents. Here, we determined whether the pharmacokinetics of viloxazine are impacted...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhao, Kosheleff, Alisa R, Adeojo, Lilian W, Odebo, Oyinkansola, Liranso, Tesfaye, Schwabe, Stefan, Nasser, Azmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752548/
https://www.ncbi.nlm.nih.gov/pubmed/34652564
http://dx.doi.org/10.1007/s13318-021-00729-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752548/
https://www.ncbi.nlm.nih.gov/pubmed/34652564
http://dx.doi.org/10.1007/s13318-021-00729-6

Ejemplares similares